Ras Al Khaimah:
Julphar Gulf Pharmaceutical Industries on Sunday said its net profit for the third quarter of this year reached Dh86 million, and that revenues for the first three quarters of this year amounted to Dh992 million. “Overall, the Mena (Middle East and North Africa) markets remained challenging for the pharmaceutical industry. Julphar’s General Manager Jerome Carle stated that the company’s management has undertaken cost-saving initiatives and new projects “to optimise processes further and consolidate our current market shares”. he added that Saudi Arabia remained Julphar’s major revenue contributor despite the current market situation there.
